{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:46:40Z","timestamp":1787507200193,"version":"build-2736575974"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis Plus"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.athplu.2023.12.003","type":"journal-article","created":{"date-parts":[[2023,12,17]],"date-time":"2023-12-17T01:33:34Z","timestamp":1702776814000},"page":"5-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controls"],"prefix":"10.1016","volume":"55","author":[{"given":"Iris M.","family":"Harmsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L.J.","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim A.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilko","family":"Spiering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.athplu.2023.12.003_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejmg.2018.05.020","article-title":"The prevalence of pseudoxanthoma elasticum: revised estimations based on genotyping in a high vascular risk cohort","volume":"62","author":"Kranenburg","year":"2019","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.athplu.2023.12.003_bib2","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/jid.2013.20","article-title":"Pseudoxanthoma elasticum: progress in research toward treatment: summary of the 2012 PXE international research meeting","volume":"133","author":"Uitto","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.athplu.2023.12.003_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1517\/21678707.2014.908702","article-title":"Pseudoxanthoma elasticum: diagnostic features, classification, and treatment options","volume":"2","author":"Uitto","year":"2014","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/j.athplu.2023.12.003_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1002\/ajmg.a.33329","article-title":"Proposal for updating the pseudoxanthoma elasticum classification system and a review of the clinical findings","volume":"152A","author":"Plomp","year":"2010","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.athplu.2023.12.003_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13023-017-0639-8","article-title":"Pseudoxanthoma elasticum","volume":"12","author":"Germain","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.athplu.2023.12.003_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jns.2016.12.053","article-title":"Cerebral disease in a nationwide Dutch pseudoxanthoma elasticum cohort with a systematic review of the literature","volume":"373","author":"Kauw","year":"2017","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.athplu.2023.12.003_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096003","article-title":"The contribution of arterial calcification to peripheral arterial disease in pseudoxanthoma elasticum","volume":"9","author":"Leftheriotis","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.athplu.2023.12.003_bib8","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1016\/j.jid.2017.06.006","article-title":"Plasma PPi deficiency is the major, but not the exclusive, cause of ectopic mineralization in an Abcc6(-\/-) mouse model of PXE","volume":"137","author":"Zhao","year":"2017","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.athplu.2023.12.003_bib9","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/jid.2008.212","article-title":"Pseudoxanthoma elasticum is a metabolic disease","volume":"129","author":"Jiang","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.athplu.2023.12.003_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ajpath.2018.09.014","article-title":"Pseudoxanthoma elasticum as a paradigm of heritable ectopic mineralization disorders: pathomechanisms and treatment development","volume":"189","author":"Li","year":"2019","journal-title":"Am J Pathol"},{"key":"10.1016\/j.athplu.2023.12.003_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12031047","article-title":"Plasma level of pyrophosphate is low in pseudoxanthoma elasticum owing to mutations in the ABCC6 gene, but it does not correlate with ABCC6 genotype","volume":"12","author":"Koz\u00e1k","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.athplu.2023.12.003_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12051893","article-title":"Inorganic pyrophosphate plasma levels are decreased in pseudoxanthoma elasticum patients and heterozygous carriers but do not correlate with the genotype or phenotype","volume":"12","author":"Van Gils","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.athplu.2023.12.003_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11092588","article-title":"Relationships between plasma pyrophosphate, vascular calcification and clinical severity in patients affected by pseudoxanthoma elasticum","volume":"11","author":"Leftheriotis","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.athplu.2023.12.003_bib14","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tibs.2018.10.005","article-title":"A mysterious inborn error clarified","volume":"44","author":"Borst","year":"2019","journal-title":"Trends Biochem Sci"},{"key":"10.1016\/j.athplu.2023.12.003_bib15","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1002\/1873-3468.13981","article-title":"From membrane to mineralization: the curious case of the ABCC6 transporter","volume":"594","author":"Verschuere","year":"2020","journal-title":"FEBS Lett"},{"key":"10.1016\/j.athplu.2023.12.003_bib16","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s100380170003","article-title":"ABCC6 gene polymorphism associated with variation in plasma lipoproteins","volume":"46","author":"Wang","year":"2001","journal-title":"J Hum Genet"},{"key":"10.1016\/j.athplu.2023.12.003_bib17","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1194\/jlr.P008268","article-title":"Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart disease","volume":"51","author":"Peloso","year":"2010","journal-title":"J Lipid Res"},{"key":"10.1016\/j.athplu.2023.12.003_bib18","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.jacc.2021.06.049","article-title":"Medial arterial calcification: JACC state-of-the-art review","volume":"78","author":"Lanzer","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.athplu.2023.12.003_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41572-019-0106-z","article-title":"Atherosclerosis","volume":"5","author":"Libby","year":"2019","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.athplu.2023.12.003_bib20","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s12944-018-0943-x","article-title":"Abcc6 deficiency in mice leads to altered ABC transporter gene expression in metabolic active tissues","volume":"18","author":"Ibold","year":"2019","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.athplu.2023.12.003_bib21","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddi183","article-title":"Disruption of Abcc6 in the mouse: novel insight in the pathogenesis of pseudoxanthoma elasticum","volume":"14","author":"Gorgels","year":"2005","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.athplu.2023.12.003_bib22","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/s41598-021-82966-y","article-title":"ABCC6 deficiency promotes dyslipidemia and atherosclerosis","volume":"11","author":"Brampton","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.athplu.2023.12.003_bib23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1476-511X-13-118","article-title":"ABCC6- a new player in cellular cholesterol and lipoprotein metabolism?","volume":"13","author":"Kuzaj","year":"2014","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.athplu.2023.12.003_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/j.athplu.2023.12.003_bib25","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2296-4-18","article-title":"Statins in hypercholesterolaemia: a dose-specific meta-analysis of lipid changes in randomised, double blind trials","volume":"4","author":"Edwards","year":"2003","journal-title":"BMC Fam Pract"},{"key":"10.1016\/j.athplu.2023.12.003_bib26","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.atherosclerosis.2014.10.105","article-title":"Achieving goal lipid levels with ezetimibe plus statin add-on or switch therapy compared with doubling the statin dose. A pooled analysis","volume":"237","author":"Ambegaonkar","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2023.12.003_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.athplu.2023.12.003_bib28","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jacl.2017.05.007","article-title":"Lipid and lipoprotein reference values from 133,450 Dutch Lifelines participants: age- and gender-specific baseline lipid values and percentiles","volume":"11","author":"Balder","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.athplu.2023.12.003_bib29","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1093\/ije\/dyu229","article-title":"Cohort Profile: LifeLines, a three-generation cohort study and biobank","volume":"44","author":"Scholtens","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.athplu.2023.12.003_bib30","series-title":"Fitting distributions to given data or known quantiles","year":"2017"},{"key":"10.1016\/j.athplu.2023.12.003_bib31","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"}],"container-title":["Atherosclerosis Plus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667089523000500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:45:42Z","timestamp":1763023542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667089523000500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":31,"alternative-id":["S2667089523000500"],"URL":"https:\/\/doi.org\/10.1016\/j.athplu.2023.12.003","relation":{},"ISSN":["2667-0895"],"issn-type":[{"value":"2667-0895","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma lipids in Pseudoxanthoma Elasticum (PXE) patients: A comparative study with population-based reference values and Non-PXE controls","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis Plus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.athplu.2023.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}